SAN MARCOS, Texas, Oct. 16 /PRNewswire/ -- Today, Grifols S.A. (Grifols), a global healthcare company based in Barcelona, Spain, broke ground on a new national testing laboratory in San Marcos, Texas at a ceremony that included Federal, state and local officials. Construction of the laboratory represents the first phase of a multi-phase expansion that includes additional warehousing and production facilities. When completed, the new facilities will represent a $76 million capital investment and will complement Grifols' existing facilities in Los Angeles, California and Barcelona, Spain.
"San Marcos is proud to help bring the first global healthcare manufacturing facility of this type to the State of Texas," said San Marcos Mayor Susan Narvaiz. "This project represents a significant partnership with Grifols, the City of San Marcos, the State of Texas, and Hays County to create new jobs and a facility that will manufacture life-saving medicines."
"As the mother of a child who uses a plasma medicine and as an advocate for people with primary immunodeficiency diseases, Grifols expansion in San Marcos gives me great comfort that families like mine will have access to life-saving plasma medicines for years to come," said Kathy Antilla, Director of Education for the Immune Deficiency Foundation, the national patient organization for people with primary immunodeficiency (PIDD) diseases. The plasma medicines Grifols produces are used to treat a variety of rare, chronic and often life-threatening diseases such as PIDD, hemophilia and other bleeding disorders, as well as shock, trauma and burns.
"We are pleased to make San Marcos home to our new facilities," said Gregory Rich, President of Grifols, Inc., the company's US division. "Business incentives offered by the City, County and State have helped us realize the goal of preparing for future patient needs of the critically important plasma medicines that we produce." Texas is i
|SOURCE Grifols S.A.|
Copyright©2009 PR Newswire.
All rights reserved